Sponsor Pipeline

Geneos Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT07722741
Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in…		 Trial sites expanded: 3 -> 8 locations
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-23 NCT07722741 Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07722741 Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in… HCC Not Yet Recruiting
Phase 1/2
NCT04251117 GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With… HCC Active, Not Recruiting
Disease Areas
Liver Cancer (2)
Get alerts when Geneos Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free